Search :
Sign in or Register  
Welcome Sign in or Don't have an account?Register

Mouse Anti-LPA Recombinant Antibody (8F6A9, 8H5C5) (CBMAB-AO703LY)

Online Inquiry

Summary

Host Animal
Mouse
Specificity
Human
Clone
8F6A9, 8H5C5
Antibody Isotype
IgG1
Application
ELISA, WB, IHC

Basic Information

Immunogen
Purified recombinant fragment of LPA (aa4330-4521) expressed in E. coli.
Specificity
Human
Antibody Isotype
IgG1
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Format
Ascites
Preservative
0.03% sodium azide
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freezethaw cycles.

Target

Full Name
S. aureus MAGI2
Entrez Gene ID
UniProt ID
Alternative Names
Apolipoprotein(a); Apo(a); Lp(a); LPA; AK38; APOA
Function
Apo(a) is the main constituent of lipoprotein(a) (Lp(a)). It has serine proteinase activity and is able of autoproteolysis. Inhibits tissue-type plasminogen activator 1. Lp(a) may be a ligand for megalin/Gp 330.
Biological Process
Blood circulationManual Assertion Based On ExperimentTAS:ProtInc
Lipid metabolic process1 PublicationNAS:ProtInc
Lipid transportIEA:UniProtKB-KW
ProteolysisManual Assertion Based On ExperimentIBA:GO_Central
Cellular Location
Extracellular region
Extracellular space
Extrinsic component of plasma membrane
Plasma lipoprotein particle
PTM
N- and O-glycosylated. The N-glycans are complex biantennary structures present in either a mono- or disialylated state. The O-glycans are mostly (80%) represented by the monosialylated core type I structure, NeuNAcalpha2-3Galbeta1-3GalNAc, with smaller amounts of disialylated and non-sialylated O-glycans also detected.
More Infomation

Lau, F. D., & Giugliano, R. P. (2022). Lipoprotein (a) and its significance in cardiovascular disease: a review. Jama Cardiology.

Coassin, S., & Kronenberg, F. (2022). Lipoprotein (a) beyond the kringle IV repeat polymorphism: the complexity of genetic variation in the LPA gene. Atherosclerosis, 349, 17-35.

Gu, J. X., Huang, J., Li, S. S., Zhou, L. H., Yang, M., Li, Y., ... & Su, M. (2022). Elevated lipoprotein (a) and genetic polymorphisms in the LPA gene may predict cardiovascular events. Scientific Reports, 12(1), 3588.

Kamstrup, P. R. (2021). Lipoprotein (a) and cardiovascular disease. Clinical chemistry, 67(1), 154-166.

Trinder, M., Uddin, M. M., Finneran, P., Aragam, K. G., & Natarajan, P. (2021). Clinical utility of lipoprotein (a) and LPA genetic risk score in risk prediction of incident atherosclerotic cardiovascular disease. JAMA cardiology, 6(3), 287-295.

Ruscica, M., Sirtori, C. R., Corsini, A., Watts, G. F., & Sahebkar, A. (2021). Lipoprotein (a): Knowns, unknowns and uncertainties. Pharmacological research, 173, 105812.

Miksenas, H., Januzzi, J. L., & Natarajan, P. (2021). Lipoprotein (a) and cardiovascular diseases. JAMA, 326(4), 352-353.

Schachtl-Riess, J. F., Kheirkhah, A., Grüneis, R., Di Maio, S., Schoenherr, S., Streiter, G., ... & Coassin, S. (2021). Frequent LPA KIV-2 variants lower lipoprotein (a) concentrations and protect against coronary artery disease. Journal of the American College of Cardiology, 78(5), 437-449.

Langsted, A., Kamstrup, P. R., & Nordestgaard, B. G. (2019). High lipoprotein (a) and high risk of mortality. European heart journal, 40(33), 2760-2770.

Ask a question We look forward to hearing from you.
0 reviews or Q&As
Loading...
Have you used Mouse Anti-LPA Recombinant Antibody (8F6A9, 8H5C5)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Learn more

Documents

Online Inquiry